Announced Thu, 9 Jul · 11:09 IST
Quarterly compliance certificate filed with exchanges for Q1 FY27
Compliance View source PDF
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.1%1-day move
₹86.50
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+0.1+4.0+4.2+0.3+0.6+3.3————
Up moveDown movePending
AI summary
Indo Us Biotech Limited has submitted a quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The certificate, issued by its Registrar and Share Transfer Agent Bigshare Services, confirms no securities were received for dematerialisation during the quarter. No certificates were cancelled and no name substitutions were made in the register of members. This is a routine regulatory filing required of all listed companies.
Likely market impact
Routine compliance filing with no material impact on business or shareholders.